Question 1

What is the catalog number for Tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2 (3H) -carboxylate?

Accepted Answer

The catalog number for Tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2 (3H) -carboxylate is OR315561.

Question 2

What sizes are available for Tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2 (3H) -carboxylate?

Accepted Answer

Tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2 (3H) -carboxylate is available in the following size(s): 1 Each.

Question 3

Is Tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2 (3H) -carboxylate in stock?

Accepted Answer

Tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2 (3H) -carboxylate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 5

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Question 6

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2 (3H) -carboxylate

Product Specifications

CAS Number

MDL Number

Purity

Smiles

Frequently Asked Questions

Explore Other Products

PAX6 (PAX6/1166), CF568 conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (rAKT1/2491), Biotin conjugate, 0.1mg/mL

Nuclear Antigen (Pan-Nuclear Marker) (NM2984R), CF405S conjugate, 0.1mg/mL

CD106 / VCAM1 (B-K9), CF488A conjugate, 0.1mg/mL

CD40 / TNFRSF5 / CD40L-Receptor (C40/2383), 0.2mg/mL

RET Proto-oncogene (RET/2976), CF640R conjugate, 0.1mg/mL